Your browser doesn't support javascript.
loading
Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection.
Martel-Laferrière, V; Brinkley, S; Bichoupan, K; Posner, S; Stivala, A; Perumalswami, P; Schiano, Td; Sulkowski, M; Dieterich, Dt; Branch, Ad.
Affiliation
  • Martel-Laferrière V; Department of Medicine, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
HIV Med ; 15(2): 108-15, 2014 Feb.
Article in En | MEDLINE | ID: mdl-24025147
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Oligopeptides / Ribavirin / HIV Infections / Serine Proteinase Inhibitors / Interferon-alpha / Hepatitis C Type of study: Etiology_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2014 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Oligopeptides / Ribavirin / HIV Infections / Serine Proteinase Inhibitors / Interferon-alpha / Hepatitis C Type of study: Etiology_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2014 Document type: Article Affiliation country: Country of publication: